1,2-dimyristoylphosphatidylethanolamine has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, LF; Jemiola-Rzeminska, M; Strzalka, K; Suwalsky, M; Zambrano, P | 1 |
| Aguilar, LF; Gallardo, MJ; Jemiola-Rzeminska, M; Sepúlveda, B; Strzalka, K; Suwalsky, M; Zambrano, P | 1 |
| Jemiola-Rzeminska, M; Strzalka, K; Suwalsky, M; Villena, F; Zambrano, P | 1 |
3 other study(ies) available for 1,2-dimyristoylphosphatidylethanolamine and Alzheimer Disease
| Article | Year |
|---|---|
An in vitro study on the interaction of the anti-Alzheimer drug rivastigmine with human erythrocytes.
Topics: Acetylcholinesterase; Alzheimer Disease; Calorimetry, Differential Scanning; Cell Shape; Cholinesterase Inhibitors; Dimyristoylphosphatidylcholine; Erythrocyte Membrane; Erythrocytes; Humans; Microscopy, Electron, Scanning; Models, Molecular; Phosphatidylethanolamines; Phospholipids; Rivastigmine; Spectrometry, Fluorescence; X-Ray Diffraction | 2020 |
The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Dimyristoylphosphatidylcholine; Donepezil; Erythrocyte Membrane; Erythrocytes; Humans; Nootropic Agents; Phosphatidylethanolamines | 2019 |
In vitro effects of the anti-Alzheimer drug memantine on the human erythrocyte membrane and molecular models.
Topics: Alzheimer Disease; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Humans; Lipid Bilayers; Lipids; Liposomes; Memantine; Microscopy, Electron, Scanning; Molecular Conformation; Phosphatidylcholines; Phosphatidylethanolamines; Thermodynamics; X-Ray Diffraction | 2017 |